Hepatitis B Vaccine Administration and Communication Policies in Rural Colorado Hospitals

Abstract

Get full access to this article

View all access options for this article.

References

1. Wainwright RB , Bulkow LR , Parkinson AJ , et al. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-results of a 10-year study. JInfect Dis. 1997;175:674-677.

2. Centers for Disease Control and Prevention . Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMVWR 1991;40 (RR-13):1-19.

3. Committee on Infectious Diseases , American Academy of Pediatrics . Universal hepatitis B immunization. Pediatrics. 1992;89:795-800.

4. Colorado Department of Public Health and Environment . Hepatitis B Prevention 1995 Annual Summary. Denver, CO: CDPHE; 1996.

5. Centers for Disease Control and Prevention . Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMVV 1999;48:563-565.

6. Centers for Disease Control and Prevention . Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. MMWR. 1999;48: 780-782.

7. Pierce RL , Smith S , Rowe-West B , Sterritt B . Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina. Arch Pediatr Adolesc Med. 1999;153:619-623.

8. Connors CM , Miller NC , Krause VL . Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin. Aust NZ JPublic Health. 1998;22:143-145.

9. Woodruff BA , Stevenson J , Yusuf H , et al. Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991-1994. Pediatrics. 1996; 97:798-803.